BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hank T, Sandini M, Ferrone CR, Rodrigues C, Weniger M, Qadan M, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C. Association Between Pancreatic Fistula and Long-term Survival in the Era of Neoadjuvant Chemotherapy. JAMA Surg 2019;154:943-51. [PMID: 31411659 DOI: 10.1001/jamasurg.2019.2272] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Jung H, Kim HS, Kang JS, Kang YH, Sohn HJ, Byun Y, Han Y, Yun W, Cho YJ, Lee M, Kwon W, Jang J. Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis. Cancers 2022;14:4360. [DOI: 10.3390/cancers14184360] [Reference Citation Analysis]
2 Hedges EA, Khan TM, Babic B, Nilubol N. Predictors of post-operative pancreatic fistula formation in pancreatic neuroendocrine tumors: A national surgical quality improvement program analysis. Am J Surg 2022:S0002-9610(22)00452-4. [PMID: 35999087 DOI: 10.1016/j.amjsurg.2022.07.007] [Reference Citation Analysis]
3 Pillny C, Teschke J, Enderes J, Manekeller S, Kalff JC, Glowka TR. Delayed Gastric Emptying Does Not Influence Cancer-Specific Survival after Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. JCM 2022;11:4200. [DOI: 10.3390/jcm11144200] [Reference Citation Analysis]
4 Kolbinger FR, Lambrecht J, Leger S, Ittermann T, Speidel S, Weitz J, Hoffmann RT, Distler M, Kühn JP. The image-based preoperative fistula risk score (preFRS) predicts postoperative pancreatic fistula in patients undergoing pancreatic head resection. Sci Rep 2022;12:4064. [PMID: 35260701 DOI: 10.1038/s41598-022-07970-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ludwig S, Distler M, Schubert U, Schmid J, Thies H, Welsch T, Hempel S, Tonn T, Weitz J, Bornstein SR, Ludwig B. Quality of life and metabolic outcomes after total pancreatectomy and simultaneous islet autotransplantation. Commun Med 2022;2. [DOI: 10.1038/s43856-022-00087-7] [Reference Citation Analysis]
6 Deig CR, Sutton TL, Beneville B, Trone K, Stratton A, Gunesch AN, Liu AI, Alrohaibani A, Mohebnasab M, Bassale S, Grossblatt-Wait A, Keith D, Attia F, Gilbert EW, Lopez CD, Kardosh A, Chen EY, Bensch KG, Nabavizadeh N, Thomas CR, Mayo SC, Sheppard BC, Grossberg A. Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications. Cancers (Basel) 2022;14:609. [PMID: 35158877 DOI: 10.3390/cancers14030609] [Reference Citation Analysis]
7 Milella M, Bassi C, Boggi U, Brunetti O, Cavaliere A, Crippa S, De Vita F, Falconi M, Frassineti GL, Giommoni E, Macchini M, Malleo G, Silvestris N, Tudisco A, Vasile E, Reni M. Evolving pancreatic cancer treatment: From diagnosis to healthcare management. Crit Rev Oncol Hematol 2021;169:103571. [PMID: 34923121 DOI: 10.1016/j.critrevonc.2021.103571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
8 Zhang T, Wu W, Yang Y, Zhao Y. The Chinese guidelines for neoadjuvant therapy of pancreatic cancer (2020). Journal of Pancreatology 2021;4:135-45. [DOI: 10.1097/jp9.0000000000000077] [Reference Citation Analysis]
9 Grego A, Friziero A, Serafini S, Belluzzi A, Moletta L, Saadeh LM, Sperti C. Does Pancreatic Fistula Affect Long-Term Survival after Resection for Pancreatic Cancer? A Systematic Review and Meta-Analysis. Cancers (Basel) 2021;13:5803. [PMID: 34830957 DOI: 10.3390/cancers13225803] [Reference Citation Analysis]
10 Kaneda Y, Kimura Y, Saito A, Ohzawa H, Ae R, Kawahira H, Lefor AK, Sata N. Innovative Pancreas Ligation Band for Distal Pancreatectomy: A Pilot In Vivo Porcine Study. Cureus 2021;13:e18238. [PMID: 34589376 DOI: 10.7759/cureus.18238] [Reference Citation Analysis]
11 Privett BJ, Perini MV, Weinberg L, Fink MA, Muralidharan V, Lee E, Starkey G, Jones R, Lin YJ, Nikfarjam M. Reduction in post-operative pancreatic fistula with polyethylene glycol and recombinant human albumin sealant following stapled distal pancreatectomy. ANZ J Surg 2021;91:2459-65. [PMID: 34514684 DOI: 10.1111/ans.17181] [Reference Citation Analysis]
12 Wang L, Zhang X, Lu Y, Tian B. Letter to the editor: the nonnegligible effect of neoadjuvant therapy for patients with borderline resectable pancreatic ductal adenocarcinoma. Gland Surg 2021;10:2340-2. [PMID: 34422605 DOI: 10.21037/gs-21-379] [Reference Citation Analysis]
13 Nappo G, Donisi G, Zerbi A. Borderline resectable pancreatic cancer: Certainties and controversies. World J Gastrointest Surg 2021; 13(6): 516-528 [PMID: 34194610 DOI: 10.4240/wjgs.v13.i6.516] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 Ju JW, Park SJ, Yoon S, Lee HJ, Kim H, Lee HC, Kim WH, Jang JY. Detrimental effect of intraoperative hypothermia on pancreatic fistula after pancreaticoduodenectomy: A single-centre retrospective study. J Hepatobiliary Pancreat Sci 2021. [PMID: 34174019 DOI: 10.1002/jhbp.1017] [Reference Citation Analysis]
15 Mikamori M, Gotoh K, Kobayashi S, Uesugi K, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Noda T, Doki Y, Eguchi H. Self-assembling peptide hydrogel SPG-178 as a pancreatic fistula-preventing agent. Langenbecks Arch Surg 2021. [PMID: 34100123 DOI: 10.1007/s00423-021-02226-5] [Reference Citation Analysis]
16 Honselmann KC, Antoine C, Frohneberg L, Deichmann S, Bolm L, Braun R, Lapshyn H, Petrova E, Keck T, Wellner U, Bausch D. A simple nomogram for early postoperative risk prediction of clinically relevant pancreatic fistula after pancreatoduodenectomy. Langenbecks Arch Surg 2021. [PMID: 34009458 DOI: 10.1007/s00423-021-02184-y] [Reference Citation Analysis]
17 van Dongen JC, Wismans LV, Suurmeijer JA, Besselink MG, de Wilde RF, Groot Koerkamp B, van Eijck CHJ. The effect of preoperative chemotherapy and chemoradiotherapy on pancreatic fistula and other surgical complications after pancreatic resection: a systematic review and meta-analysis of comparative studies. HPB (Oxford) 2021:S1365-182X(21)00143-X. [PMID: 34099372 DOI: 10.1016/j.hpb.2021.04.027] [Reference Citation Analysis]
18 Kurata Y, Shiraki T, Ichinose M, Kubota K, Imai Y. Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective. World J Surg Oncol 2021;19:85. [PMID: 33752677 DOI: 10.1186/s12957-021-02192-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Chong E, Ratnayake B, Lee S, French JJ, Wilson C, Roberts KJ, Loveday BPT, Manas D, Windsor J, White S, Pandanaboyana S. Systematic review and meta-analysis of risk factors of postoperative pancreatic fistula after distal pancreatectomy in the era of 2016 International Study Group pancreatic fistula definition. HPB (Oxford) 2021;23:1139-51. [PMID: 33820687 DOI: 10.1016/j.hpb.2021.02.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 He J, Schmocker R. Neoadjuvant Treatment and Surgical Resection Are Associated with Survival in Pancreatic Cancer. J Am Coll Surg 2021;232:1023-4. [PMID: 33722461 DOI: 10.1016/j.jamcollsurg.2021.02.006] [Reference Citation Analysis]
21 Lequeu JB, Cottenet J, Facy O, Perrin T, Bernard A, Quantin C. Failure to rescue in patients with distal pancreatectomy: a nationwide analysis of 10,632 patients. HPB (Oxford) 2021:S1365-182X(21)00036-8. [PMID: 33622649 DOI: 10.1016/j.hpb.2021.02.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Ren W, Xourafas D, Ashley SW, Clancy TE. Prognostic Factors in Patients With Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Resection. Am Surg 2021;:3134821991962. [PMID: 33522271 DOI: 10.1177/0003134821991962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Navez J, Bouchart C, Lorenzo D, Bali MA, Closset J, van Laethem JL. What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact? Ann Surg Oncol 2021. [PMID: 33479866 DOI: 10.1245/s10434-020-09568-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Yu Q, Jobin C, Thomas RM. Implications of the microbiome in the development and treatment of pancreatic cancer: Thinking outside of the box by looking inside the gut. Neoplasia 2021;23:246-56. [PMID: 33418277 DOI: 10.1016/j.neo.2020.12.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Kamarajah SK, Naffouje SA, Salti GI, Dahdaleh FS. Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission Rates: A Population-Based Cohort Study. Ann Surg Oncol 2021;28:1896-905. [PMID: 33398644 DOI: 10.1245/s10434-020-09470-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Kirkpatrick S, Gillies G, Underwood P, Cioffi J, Trevino JG, Hughes SJ. Biliary intervention rates during neoadjuvant therapy for adenocarcinoma of the pancreatic head. HPB (Oxford) 2021;23:1196-200. [PMID: 33388244 DOI: 10.1016/j.hpb.2020.11.1147] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Leon P, Panaro F. ASO Author Reflections: Exploring the Oncologic Impact of Pancreatic Fistula after Distal Pancreatectomy for Ductal Adenocarcinoma. Ann Surg Oncol 2021;28:3184-5. [PMID: 33221981 DOI: 10.1245/s10434-020-09314-8] [Reference Citation Analysis]
28 Uchida Y, Masui T, Nagai K, Anazawa T, Yoshimura M, Uza N, Takaori K, Mizowaki T, Uemoto S. Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadjuvant chemoradiotherapy: A retrospective analysis. Surg Oncol 2020;35:527-32. [PMID: 33160278 DOI: 10.1016/j.suronc.2020.10.010] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Leon P, Giannone F, Belfiori G, Falconi M, Crippa S, Boggi U, Menonna F, Al Sadairi AR, Piardi T, Sulpice L, Gardini A, Sega V, Chirica M, Ravazzoni F, Giannandrea G, Pessaux P, de Blasi V, Navarro F, Panaro F. The Oncologic Impact of Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma of the Body and the Tail: A Multicenter Retrospective Cohort Analysis. Ann Surg Oncol 2021;28:3171-83. [PMID: 33156465 DOI: 10.1245/s10434-020-09310-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Mangieri CW, Strode MA, Moaven O, Clark CJ, Shen P. Utilization of chemoradiation therapy provides strongest protective effect for avoidance of postoperative pancreatic fistula following pancreaticoduodenectomy: A NSQIP analysis. J Surg Oncol 2020;122:1604-11. [PMID: 32935353 DOI: 10.1002/jso.26202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Kamarajah SK, Bundred JR, Boyle C, Oo J, Pandanaboyana S, Loveday B. Impact of neoadjuvant therapy on post-operative pancreatic fistula: a systematic review and meta-analysis. ANZ J Surg. 2020;90:2201-2210. [PMID: 32418344 DOI: 10.1111/ans.15885] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
32 Chiarello MM, Brisinda G. An Invited Commentary on "C-reactive protein and drain amylase accurately predict clinically relevant pancreatic fistula after partial pancreaticoduodenectomy". Int J Surg 2020;77:112-3. [PMID: 32234348 DOI: 10.1016/j.ijsu.2020.03.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Angrisani M, Sandini M, Cereda M, Paiella S, Capretti G, Nappo G, Roccamatisi L, Casciani F, Caccialanza R, Bassi C, Zerbi A, Gianotti L. Preoperative adiposity at bioimpedance vector analysis improves the ability of Fistula Risk Score (FRS) in predicting pancreatic fistula after pancreatoduodenectomy. Pancreatology 2020;20:545-50. [DOI: 10.1016/j.pan.2020.01.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
34 Paniccia A, Gleisner AL, Zenati MS, Al Abbas AI, Jung JP, Bahary N, Lee KKW, Bartlett D, Hogg ME, Zeh HJ, Zureikat AH. Predictors of Disease Progression or Performance Status Decline in Patients Undergoing Neoadjuvant Therapy for Localized Pancreatic Head Adenocarcinoma. Ann Surg Oncol 2020;27:2961-71. [DOI: 10.1245/s10434-020-08257-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
35 Trudeau MT, Vollmer CM. Prognostic Value of Pancreatic Fistula in Resected Patients With Pancreatic Cancer With Neoadjuvant Therapy. JAMA Surg 2020;155:268. [DOI: 10.1001/jamasurg.2019.5090] [Reference Citation Analysis]
36 Shi S, Hua J, Yu X. Prognostic Value of Pancreatic Fistula in Resected Patients With Pancreatic Cancer With Neoadjuvant Therapy. JAMA Surg 2020;155:267. [DOI: 10.1001/jamasurg.2019.5089] [Reference Citation Analysis]
37 Hank T, Sandini M, Fernández-del Castillo C. Prognostic Value of Pancreatic Fistula in Resected Patients With Pancreatic Cancer With Neoadjuvant Therapy—Reply. JAMA Surg 2020;155:269. [DOI: 10.1001/jamasurg.2019.5091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
38 Hank T, Strobel O. Conversion Surgery for Advanced Pancreatic Cancer. J Clin Med 2019;8:E1945. [PMID: 31718103 DOI: 10.3390/jcm8111945] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]